Has Jeffrey Shy received payments from drug or device companies?

Yes. Drug and device makers reported $53,198 in general payments to Jeffrey Shy across 383 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jeffrey Shy did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jeffrey Shy come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jeffrey Shy

Neurology · Mesa, AZNPI 1831246503

Payments from drug & device makers

$53,198in general payments, 2019–2025

Across 383 payments — averaging $138.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Eisai Inc.$29K
Otsuka Pharmaceutical Development & Commercialization, Inc.$16K
Merck$3K
AbbVie$935
Amgen$698
Biogen$419
plus $4K from 45 others

What the payments were for

Speaking & faculty fees$711%
Food & beverage$5,79198%
Education$401%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Eisai Inc.	32	$28,898
Otsuka Pharmaceutical Development & Commercialization, Inc.	3	$15,925
Merck	3	$2,565
AbbVie(2 entities)	52	$935
Amgen(2 entities)	35	$698
Biogen	34	$419
UCB, Inc.	25	$337
Upsher-smith Laboratories LLC	20	$265
Supernus Pharmaceuticals, Inc.	28	$233
CSL Behring	10	$224
Sunovion Pharmaceuticals Inc.	13	$218
Lilly USA, LLC	13	$189
MDD US Operations, LLC	3	$175
AstraZeneca	8	$175
Biohaven Pharmaceuticals, Inc.	9	$148
Acadia Pharmaceuticals Inc	6	$124
EMD Serono, Inc.	5	$114
Novartis	6	$107
Johnson & Johnson	7	$105
Harmony Biosciences LLC	5	$98
Amneal Pharmaceuticals LLC	6	$95
Sanofi	4	$90
SK Life Science, Inc.	4	$85
Bristol Myers Squibb	4	$81
Acorda Therapeutics, Inc	4	$71
Medtronic(2 entities)	4	$60
Banner Life Sciences, LLC	1	$60
Abbott	3	$57
Teva Pharmaceuticals USA, Inc.	4	$54
Tanabe Pharma America, Inc.	2	$50
Genentech USA, Inc.	2	$45
Lundbeck LLC	2	$44
Strongbridge US Inc.	2	$38
Neurocrine Biosciences, Inc.	2	$38
E.r. Squibb & Sons, L.L.C.	2	$37
Almatica Pharma LLC	3	$36
Grifols USA, LLC	2	$34
Mallinckrodt Hospital Products Inc.	1	$33
Arbor Pharmaceuticals, Inc.	2	$29
Kyowa Kirin, Inc.	1	$26
Covidien LP	1	$22
Vanda Pharmaceuticals Inc.	1	$21
Otto Bock Healthcare LP	1	$18
Penumbra, Inc.	1	$18
Livanova USA, Inc.	1	$17
Collegium Pharmaceutical, Inc.	1	$16
Boston Scientific	1	$15
GRT US Holding, Inc.	1	$15
Neurelis, Inc.	1	$15
Avanir Pharmaceuticals, Inc.	1	$13
Zyla Life Sciences, Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

APOKYN$144
MYOBLOC$144
Xadago$144

How this compares

$53,198 in reported general payments places this provider in the 75th percentile of 388 neurology providers in Arizona.

See all neurology providers in Arizona →

Other neurology in Mesa

David WeidmanPhoenix$7.4M
Hemant PandeyChandler$6.2M
Stephen FlitmanPhoenix$4.4M
Barry HendinPhoenix$4.4M
Jeremy ShefnerPhoenix$3M
Danielle CabralPhoenix$2.8M
Suraj MuleyPhoenix$2.8M
Todd SchwedtPhoenix$2.8M
Todd LevinePhoenix$2.7M
Nida LaurinScottsdale$2.3M

See the full list for Arizona →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →